Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Acta Clinica Belgica|September 10, 2019
Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockadeLaila Belcaid, Soizic Garaud, Joseph Kerger, et al.Journal of Hypertension|April 25, 2015
Blockade of the renin-angiotensin system in small arteries and anticontractile function of perivascular adipose tissueClaudia Agabiti Rosei, Sarah B Withers, Laila Belcaid, et al.The Journal of Liquid Biopsy|March 3, 2025
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsClaudia Parisi, Marco Tagliamento, Laila Belcaid, et al.Clinical and Experimental Medicine|February 16, 2026
Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarkerSofiane Taleb, Maxime Brunet, Laila Belcaid, et al.Lung Cancer (Amsterdam, Netherlands)|March 21, 2023
New pathogenic germline variants identified in mesotheliomaLaila Belcaid, Birgitte Bertelsen, Karin Wadt, et al.NPJ Precision Oncology|October 7, 2024
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trialsArnaud Bayle, Laila Belcaid, Sophie Cousin, et al.Neuro-Oncology Practice|February 7, 2025
Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023Vincent Fougner, Thomas Urup, Hans Skovgaard Poulsen, et al.Molecular Cancer|November 4, 2023
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) studyArnaud Bayle, Laila Belcaid, Lola-Jade Palmieri, et al.BMC Cancer|February 23, 2023
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trialTina Kringelbach, Martin Højgaard, Kristoffer Rohrberg, et al.Radiology|November 26, 2024
Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with MetastasesLama Dawi, Younes Belkouchi, Littisha Lawrance, et al.Pageof 1